Each vial contains 10mg of highly pure VIP in lyophilized form.
VIP Peptide (Vasoactive Intestinal Peptide) is a naturally occurring 28-amino acid neuropeptide studied for its broad regulatory effects on immune function, inflammation, vascular tone, and cellular signaling. It interacts primarily with VPAC1 and VPAC2 receptors, which are widely expressed throughout the nervous, immune, respiratory, and gastrointestinal systems, making VIP an important molecule in maintaining physiological homeostasis.
Through activation of these receptors, VIP influences cyclic AMP (cAMP)-dependent signaling pathways that regulate inflammatory cytokine production, smooth muscle relaxation, vasodilation, and immune cell activity. In preclinical research, these mechanisms have been associated with reduced inflammatory signaling, enhanced tissue protection, and modulation of both innate and adaptive immune responses under a variety of experimental conditions.
Beyond its immunomodulatory effects, VIP has been extensively investigated for its potential role in supporting pulmonary function, gastrointestinal integrity, and neurological health. Experimental studies suggest that VIP may help preserve epithelial barrier function, improve local blood flow through vasodilation, and protect tissues from inflammatory and oxidative stress-related damage. These diverse biological activities have made it a valuable research tool across multiple areas of biomedical investigation.
Unlike peptides that target a single metabolic or hormonal pathway, VIP exerts pleiotropic effects through widespread receptor distribution and complex intracellular signaling networks. This broad physiological activity has led to ongoing research into its potential applications in inflammatory, autoimmune, pulmonary, neurological, and gastrointestinal models.
VIP Peptide remains an investigational research compound intended exclusively for laboratory and scientific research. It has not been approved for therapeutic use in humans, and its safety and efficacy continue to be evaluated in preclinical and clinical research settings.
